been reported secondary to adrenal masses as well as secondary to pharmaceutical agents like chloroquine. [5, 6] Rarely, TTC may occur as a complication of intra-cerebral hemorrhage. [7, 8] In this case, electrocardiogram (ECG) changes as well as brain natriuretic peptide determination help in diagnosing the TTC. Similarly, TTC may result secondary to an intra-cerebral infarction. Rarely, status migrainosus may result in cardiac changes including TTC. [9] Most patients make a complete recovery after resolution of the stressor.
TTC has also been reported following organ transplantation. For instance, Tachotti et al. have recently reported two cases of TTC that occurred following hepatic transplantation. [10] Typical apical ballooning was seen on echocardiographic examination in both the cases. Surgery like thyroidectomies may also result in TTC as a post-surgical complication. [11] Similarly, rarely, induction of general anesthesia may result in TTC. [12] Diagnostic tests like dobutamine stress echo can also result in TTC. [13] The above examples clearly illustrate that TTC may occur secondary to myriad causes ranging from burns to anesthesia induction. There is a clear need to increase awareness about this syndrome among physicians, especially cardiologists.
Author's reply
We appreciate the interest expressed by Dr. Kapoor in our published report of TTC after initiation of therapy for pulmonary arterial hypertension. [1] The importance of stress-induced cardiomyopathies, as an entity, should not be underestimated. The end result of a TTC can be devastating and fatal, especially if the clinical context is in an already clinically tenuous patient. [2] The process of treatment initiation, medical, and/or surgical, can promote enormous emotional anxieties, irrespective of the underlying disease process. [3] The entity itself, TTC, demonstrates the power of perception and its interaction with physiologic functioning. In addition, TTC reminds us of the importance of open communication as a physician. As seen in our case, despite what we perceived as open dialogue, the initiation of prostacyclin therapy led to this reaction. As Dr. Kapoor has detailed, there are a variety of clinical scenarios previously described, both life-threatening and relatively less severe, that have the potential to promote a TTC. Detailed discussion and time for processing therapeutic decisions is critical to alleviate patient concerns, although it is unclear if this will indeed alter this response. Unfortunately, it also remains unclear who will develop this type of response, and if it is preventable. We hope that our case brings about a greater awareness and earlier recognition and will perhaps promote an international registry to learn more about the entity.
